• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Marco Taglietti - Articles and news items


AstraZeneca and Forest Laboratories to initiate phase III clinical trials for ceftazidime/avibactam

Industry news, News / 18 October 2011 / AstraZeneca

ceftazidime/avibactam (CAZ-AVI) will enter phase III trials…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +